Patent application number | Description | Published |
20100009098 | ATMOSPHERIC PRESSURE PLASMA ELECTRODE - An improved electrode useful for modifying a substrate using corona discharge dielectric barrier discharge or glow discharge plasma treatment or coating a substrate using plasma enhanced chemical vapor deposition under atmospheric or near atmospheric pressure conditions, the electrode having a body defining a cavity therein, the body having at least one inlet passageway there through in gaseous communication with the cavity so that a gas mixture can be flowed into the cavity by way of the at least one inlet passageway, the electrode having at least one outlet passageway there through in gaseous communication with the cavity so that a gas that is flowed into the cavity can flow out of the cavity by way of the at least one outlet passageway, the at least one outlet passageway being a slot. The improvement is to position a porous body in the cavity sealed to the wall of the cavity adjacent to the outlet passageway so that a gas that is flowed into the cavity will pass through the porous body before flowing through the outlet passageway. | 01-14-2010 |
20110087054 | ISOTHERMAL MULTITUBE REACTORS AND PROCESSES INCORPORATING THE SAME - The present invention provides isothermal multitube reactors suitable for the production of chlorinated and/or fluorinated propene and higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes. The reactors utilize a feed mixture inlet temperature at least 20° C. different from a desired reaction temperature. | 04-14-2011 |
20110087056 | ADIABATIC PLUG FLOW REACTORS AND PROCESSES INCORPORATING THE SAME - The present invention provides adiabatic plug flow reactors suitable for the production of chlorinated and/or fluorinated propene and higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes. The reactors comprise one or more designs that minimize the production of by-products at a desired conversion. | 04-14-2011 |
20110094120 | DEVICE TO DRY CATALYST ROASTER CONVEYOR BELT AND METHOD OF USING SAME - A system and process for removing an inorganic salt from a catalyst roaster belt is disclosed. The system includes an apparatus with a drying vessel having a catalyst roaster belt inlet, a catalyst roaster belt outlet, a heating medium inlet, and a heating medium outlet, wherein the catalyst roaster belt inlet and the catalyst roaster belt outlet are spaced apart along a first direction, the heating medium inlet and the heating medium outlet are spaced apart along a second direction, the heating medium inlet is spaced apart from the catalyst roaster belt inlet in the second direction, and the catalyst roaster belt inlet is between the heating medium inlet and the heating medium outlet along the second direction. The system includes an acid bath and a moveable catalyst roaster belt extending from the acid bath through the catalyst roaster belt inlet and through the catalyst roaster belt outlet. The process includes the steps of providing a catalyst roaster belt with an inorganic salt disposed thereon and supplying a heating medium to a first side of the catalyst roaster belt such that heat from the heating medium flows through the catalyst roaster belt to a second side of the catalyst roaster belt to vaporize the inorganic salt. | 04-28-2011 |
20110228630 | Reduced Transit Static Mixer Configuration - Excessive residence time in the conduits located between the outlet of a static mixer and a reactor/separator reservoir can lead to undesired by-products, formation of solids, and conduit fouling. This disclosure relates to an improved configuration for a static mixer with reduced transitory time to help reduce the creation of undesired by-products and fouling during the process of mixing, and more particularly to a phosgene reactor comprising a short or very short conduit for reducing the transit time from the static mixer to a reactor/separator reservoir to one second or less. | 09-22-2011 |
20110268378 | Journal Bearing Design - The present disclosure relates to bearings, for example, an improved journal bearing. A bushing ( | 11-03-2011 |
20130079550 | STATIC REACTIVE JET MIXER, AND METHODS OF MIXING DURING AN AMINE-PHOSGENE MIXING PROCESS - This disclosure relates to a static mixer ( | 03-28-2013 |
20130211118 | ORGANOMETALLIC COMPOUND PREPARATION - A method of continuously manufacturing organometallic compounds is provided where two or more reactants are conveyed to a reactor having a laminar flow contacting zone, a heat transfer zone, and a mixing zone having a turbulence-promoting device; and causing the reactants to form the organometallic compound. | 08-15-2013 |
20130270356 | APPARATUS AND METHOD FOR PRODUCING FREE-STANDING MATERIALS - An apparatus includes a manifold with a chamber for mixing multiple reactants. Gases are jetted into the manifold by a plurality of inlet injectors. The inlet injectors are arranged such that the gases passing into the manifold impinge on each other at a common point to form a mixture. The mixture passes through a plurality of holes in one side of the manifold into a deposition chamber where the mixture of gases impinges on additional gases at a common point to provide a reaction resulting in deposition of solid materials in the deposition chamber. The solid materials are free-standing. | 10-17-2013 |
Patent application number | Description | Published |
20090281049 | New use of ginsenoside compound-k in manufacturing medicaments - Use of ginsenoside Compound-K, which structural formula is the following: | 11-12-2009 |
20100286437 | PREPATATION METHOD OF RIVASTIGMINE, ITS INTERMEDIATES AND PREPARATION METHOD OF THE INTERMEDIATES - The present invention provides N-methylethylcarbamino-3-[(S)-1-(methyl-[(S)-1-phenylethyl]amino)ethyl]phenyl ester represented by formula (II) and its preparation method. The present invention also provides (S)-1-(3-methoxyphenyl)-N-methyl-N—[(S)-1-phenylethyl]ethylamine and 3-[(S)-1-(methyl-[(S)-1-phenylethyl]amino)ethyl]phenol as intermediates of the compound represented by formula (II), and the use of the compound represented by formula (II) for preparing rivastigmine used for treating Alzheimer disease. | 11-11-2010 |
20100311796 | METHOD FOR THE SEPARATION AND PURIFICATION OF EPOTHILONES - The invention discloses a method for the separation and purification of epothilones, especially discloses a method for the separation and purification of epothilones B and A using normal phase silica gel chromatography, which comprises loading the sample after dissolving the sample containing epothilones B and A with C | 12-09-2010 |
20120208994 | AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF - Preparation of azetidinone compounds and medical use thereof are provided by the present invention. More particularly, azetidionne compounds, shown as formula (I), wherein R | 08-16-2012 |
20130089613 | Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses - Phenyl propanoic acid compounds having activating effect on peroxisome proliferator-activated receptors (PPARα,δ,γ) and a preparation method and uses thereof are provided in the present invention. The compounds can be used for treating or preventing diseases associated with peroxisome proliferator-activated receptors (PPARα,δ,γ). | 04-11-2013 |
20130225810 | BENZAMIDE DERIVATIVE WITH ANTICANCER ACTIVITY AND PREPARATION METHOD AND USE THEREOF - Provided are a benzamide derivative as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the preparation method and use thereof for preparing a medicine for treating cancer, wherein the group definitions of formula (I) are as set out in the description. | 08-29-2013 |
20140011867 | EFFECT OF BORRELIDIN FOR CONTROLLING SOYBEAN PHYTOPHTHORA ROOT ROT - The present invention discloses use of borrelidin for preventing and controlling | 01-09-2014 |
20140073809 | PREPARATION METHOD FOR RIVASTIGMINE, INTERMEDIATES THEREOF, AND PREPARATION METHOD FOR SAID INTERMEDIATES - The present invention provides the preparation method for (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (formula X compound), the preparation methods for its intermediates (S)-1-(3-methoxyphenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula VI compound), (S)-1-(3-hydroxyphenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula VIII compound) and (S)-1-(3-(ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula IX compound), as well as the method for using above mentioned formula IX compound to prepare rivastigmine which can be used for the treatment of Alzheimer's disease. The preparation method for rivastigmine has a reasonable synthetic design with convenient source of raw materials and high total yield, and the product resulted has high chemical and optical purity, which makes it easy for large-scale. industrial production. | 03-13-2014 |
20140378488 | 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF - Provided are derivatives substituted by urea associated with 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine-2-amino of formula (I), wherein these compounds may selectively regulate or inhibit an information transmission process controlled by natural or variant tyrosine kinase. Also provided are preparation methods and uses of the compounds. | 12-25-2014 |
20150057440 | TWO CRYSTAL FORMS OF GINSENOSIDE C-K AND METHOD FOR PREPARING SAME - Provided are ginsenoside C-K polymorphic forms and a method for preparing same. The ginsenoside C-K polymorphic forms are crystal form D and crystal form H. | 02-26-2015 |
20150065699 | GINSENOSIDE C-K POLYMORPHIC COMPOUNDS AND METHOD FOR PREPARING SAME - Provided are several types of ginsenoside polymorphic substances and a method for preparing same. In particular, new crystal form A, crystal form B, crystal form C, crystal form E, crystal form F, crystal form I, crystal form K, crystal form L, crystal form M, crystal form N, and crystal form O are involved. | 03-05-2015 |